Grape King Bio Ltd (1707.TW)

TWD 151.0

(0.0%)

Net Income Summary of Grape King Bio Ltd

  • Grape King Bio Ltd's latest annual net income in 2023 was 1.45 Billion TWD , down -33.04% from previous year.
  • Grape King Bio Ltd's latest quarterly net income in 2024 Q2 was 327.75 Million TWD , up 27.1% from previous quarter.
  • Grape King Bio Ltd reported an annual net income of 2.16 Billion TWD in 2022, up 11.38% from previous year.
  • Grape King Bio Ltd reported an annual net income of 1.94 Billion TWD in 2021, up 2.79% from previous year.
  • Grape King Bio Ltd reported a quarterly net income of 257.88 Million TWD for 2024 Q1, down -44.94% from previous quarter.
  • Grape King Bio Ltd reported a quarterly net income of 337.87 Million TWD for 2023 Q2, down -17.74% from previous quarter.

Annual Net Income Chart of Grape King Bio Ltd (2023 - 2006)

Historical Annual Net Income of Grape King Bio Ltd (2023 - 2006)

Year Net Income Net Income Growth
2023 1.45 Billion TWD -33.04%
2022 2.16 Billion TWD 11.38%
2021 1.94 Billion TWD 2.79%
2020 1.89 Billion TWD -2.24%
2019 1.93 Billion TWD 49.65%
2018 1.29 Billion TWD -4.18%
2017 1.35 Billion TWD 4.25%
2016 1.29 Billion TWD 23.31%
2015 1.05 Billion TWD 11.58%
2014 942.48 Million TWD 12.77%
2013 835.76 Million TWD 35.04%
2012 618.9 Million TWD 30.83%
2011 473.06 Million TWD 10.61%
2010 427.7 Million TWD 12.75%
2009 379.34 Million TWD 130.57%
2008 164.52 Million TWD -9.04%
2007 180.87 Million TWD 20.24%
2006 150.42 Million TWD 0.0%

Peer Net Income Comparison of Grape King Bio Ltd

Name Net Income Net Income Difference
Standard Chem & Pharm CO., LTD. 834.88 Million TWD -74.003%
Maywufa Company Ltd. 169.09 Million TWD -759.104%
ScinoPharm Taiwan, Ltd. 287.05 Million TWD -406.078%
Lotus Pharmaceutical Co., Ltd. 4.1 Billion TWD 64.616%
LIWANLI Innovation Co., Ltd. 5.1 Million TWD -28368.117%
YungShin Global Holding Corporation 827.3 Million TWD -75.598%
PhytoHealth Corporation -47.11 Million TWD 3183.235%
SCI Pharmtech, Inc. 294.72 Million TWD -392.916%
Formosa Laboratories, Inc. 126.24 Million TWD -1050.739%
PharmaEssentia Corporation -623.83 Million TWD 332.871%
Bora Pharmaceuticals Co., LTD. 3.03 Billion TWD 52.057%